AzTrials
AzTrials

Gag ReflexNCT07069686

US-guided Airway Nerve Block vs. Topical Lidocaine in Video Laryngoscopy for Difficult Bariatric Intubation.

A study testing Ultrasound guided airway nerve block for Endotracheal intubation and lidocaine topical anesthesia for Endotracheal intubation in people with Gag Reflex, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will test the effects of ultrasound guided airway nerve block vs lidocaine topical anesthesia and it's direct effect in decreasing incidence of gag and cough reflex in suspected difficult intubation patients using video assisted laryngoscopey for those Undergoing bariatric surgery Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Gag Reflex
What is being tested?
Ultrasound guided airway nerve block for Endotracheal intubation and lidocaine topical anesthesia for Endotracheal intubation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteEgypt
Study dates
20 Feb 2025to 28 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age: 21-65 years old
  • Obese patients (BMI>35 kg/m2) undergoing bariatric surgery
  • Suspected difficult intubation: e.g:(Mallampati score ≥3 , Thyromental distance <6 cm, Limited neck mobility, History of difficult intubation)
  • ASA I-II

Who cannot join

  • Patients at increased risk for aspiration (e.g., full stomach or gastro-esophageal reflux disease) and pregnancy
  • Patients with expected difficult ventilation
  • Patients who have upper airway pathology or surgery
  • Patients with a mouth opening < 2 cm
  • ASA III-IV
  • Emergency surgery
Show all 12Show fewer
  • Allergy to local anesthetics
  • Contraindication to nerve blocks e.g.:(Coagulopathy, Infection at site of injection)
  • Patient refusal
  • Neurological or cognitive impairment making the patient uncooperative
  • History of difficult airway complications e.g.: previous intubation failure or need for surgical airway
  • Cervical spine instability or fractures

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams University

    Cairo, Egypt, 11111

Other trials in Egypt

About this study

Official title: Ultrasound-Guided Airway Nerve Blocks vs. Lidocaine Topical Anesthesia Using Video-Assisted Laryngoscopy in Suspected Difficult Intubation for Patients Undergoing Bariatric Surgery

The investigators will test the effects of ultrasound guided airway nerve block vs lidocaine topical anesthesia and it's direct effect in decreasing incidence of gag and cough reflex in suspected difficult intubation patients using video assisted laryngoscopey for those Undergoing bariatric surgery

Read the detailed description

A.Preoperative settings:

A thorough preoperative evaluation including a complete airway evaluation (mouth opening, mallampati grading, body weight, thyromental distance, and evaluation of dentition) will be performed. Standard fasting guidelines and anti-aspiration prophylaxis with tablet ranitidine 150 mg will be prescribed.

The patients will be explained about the awake C-MAC intubation during preoperative assessment.Injection of atropine 0.4 mg will be given half an hour before shifting the patient to the operating room (OR).

B.Intraoperative and postoperative settings:

Injection of atropine 0.4 mg will be given half an hour before shifting the patient to the operating room (OR). Inside the OR, standard monitoring, including electrocardiography (ECG), noninvasive blood pressure (BP), and pulse oximetry (SpO2) will be applied in all patients. An intravenous (IV) line will be secured and ringer lactate will be started. After recording the baseline heart rate (HR), BP and SpO2, Injection of Dexametomidate 0.7 mcg/kg/hr IV infusion and injection ketamine 0.5-2 mg/kg slow IV single dose until endotracheal tube secured.

For each group, local anesthetics will be given in first group (LA)guided by ultrasound and second group (T) with topical method until Adequate effect of local anesthesia confirmed by hoarseness of voice in Group LA patients and numbness of tongue in Group T patients. While giving supplemental oxygen through nasal prongs, C-MAC intubation will be performed. After the airway is secured, general anesthesia will be administered with propofol 2 mg/kg, and rocuronium 0.6 mg/kg.

Postoperatively, patient comfort will be assessed for sore throat, dysphagia, voice change, or any lip, gum, tongue, dental injuries, complete amnesia, partial recall, and unpleasant memories during awake C-MAC intubation.

Conditions
Gag Reflex
Being tested
Ultrasound guided airway nerve block for Endotracheal intubation, lidocaine topical anesthesia for Endotracheal intubation
Medical subject headings
Gagging

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound guided airway nerve block for Endotracheal intubationProcedure or surgery

    Glossopharyngeal nerve block: 1.5 mL 2% lidocaine, ultrasound probe on lateral neck below mandible, landmark = hyoid bone, tilt cephalad to target pharyngeal wall near tonsil; right side needle inserted out-of-plane from superior probe edge to avoid artery. Bilateral superior laryngeal nerve blocks: out-of-plane at lateral thyroid cartilage, orient probe medially, inject 1 mL 2% lidocaine into thyrohyoid membrane between hyoid and thyroid cartilage using 25-G 25 mm needle. Bilateral recurrent laryngeal nerve blocks: translaryngeal out-of-plane, locate cricothyroid membrane below thyroid cartilage, insert 25-G 25 mm needle 1.5 cm, confirm air backflow, inject 2 mL 2% lidocaine.

  • lidocaine topical anesthesia for Endotracheal intubationProcedure or surgery

    will receive topical lidocaine 10% spray directly on the tongue and oropharynx without exceeding toxic doses.

Study groups in NCT07069686
Study groupRoleWhat they receive
Group LAActive comparatorpatients will be intubated using the video-assisted laryngoscope after taking airway nerves block guided by ultrasound device
Receives: Procedure: Ultrasound guided airway nerve block for Endotracheal intubation
Group TActive comparatorpatients will be intubated using the video-assisted laryngoscope after topical lidocaine 10% spraying as-you-go to oro-pharyngeo-laryngeal cavity without exceeding the toxic dose.
Receives: Procedure: lidocaine topical anesthesia for Endotracheal intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Gag reflex and cough reflex

    After taking local anesthesia monitoring of gag and cough reflexes will be monitored during the process of endotracheal intubation

    Measured: After applying local anesthesia by at least 3 minutes

Secondary outcomes (1)
  1. Mean blood pressure (MAP)

    After taking local anesthesia monitoring of Mean blood pressure (MAP) will be monitored during the process of endotracheal intubation

    Measured: After applying local anesthesia by at least 3 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2025
  2. Study start20 Feb 2025
  3. Primary completion28 May 2025
  4. Study completion28 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07069686
Sponsor's protocol ID
FMASU MS 120/2025
Status last verified
Feb 2025
First submitted
15 Jun 2025
Last updated
17 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All data will be shared once study is completed

Publications

  • Hashim RM, Zaki MSM, Elagiby DBN, Taher IAA. Ultrasound-Guided Airway Nerve Blocks vs. Lidocaine Topical Anesthesia Using Video-Assisted Laryngoscopy in Suspected Difficult Intubation for Patients Undergoing Bariatric Surgery: A Randomized Clinical Trial. Anesthesiol Res Pract. 2026 May 22;2026:2054379. doi: 10.1155/anrp/2054379. eCollection 2026.

    PubMed 42180592

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound guided airway nerve block for Endotracheal intubation and lidocaine topical anesthesia for Endotracheal intubation in people with Gag Reflex, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Gag reflex and cough reflex (time frame: After applying local anesthesia by at least 3 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07069686, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in